1209490-17-4

Upstream product

• 724422-42-8 6-bromo-2-methyl-3,4-dihydroisoquinolin-1(2H)-one 
• 1209528-84-6 C₁₃H₁₄N₄O₂ 
• 1200497-67-1 C₁₂H₁₇N₃O₄ 
• 1200497-71-7 C₁₁H₁₅N₃O₄ 
• 1209488-57-2 C₁₈H₂₂N₄O₄ 

Downstream Products

• 1253409-08-3 C₂₇H₃₂N₆O₂ 

Relevant academic research and scientific papers

UREA DERIVATIVE HAVING PI3K INHIBITORY ACTIVITY

Provided is a compound or a pharmaceutically acceptable salt thereof which inhibits the activity of PI3K to regulate many biological processes including the growth, differentiation, survival, proliferation, migration, metabolism, and the like of cells and is therefore useful for the prophylaxis/therapy of diseases including inflammatory diseases, arteriosclerosis, vascular/circulatory diseases, cancer/tumors, immune system diseases, cell proliferative diseases, infectious diseases, and the like. The above problem was solved by providing a urea derivative shown in the present specification, or a pharmaceutically acceptable salt thereof.

RING-FUSED AZOLE DERIVATIVE HAVING PI3K-INHIBITING ACTIVITY

It is an object of the present invention to provide a compound or a pharmaceutically acceptable salt thereof which inhibits the activity of PI3K to regulate many biological processes including the growth, differentiation, survival, proliferation, migration, metabolism, and the like of cells and is therefore useful for the prophylaxis/therapy of diseases including inflammatory diseases, arteriosclerosis, vascular/circulatory diseases, cancer/tumors, immune system diseases, cell proliferative diseases, infectious diseases, and the like. The above problem was solved by providing a ring-fused azole compound shown in the present specification, or a pharmaceutically acceptable salt thereof.